Saida, Takahiko
Kira, Jun-Ichi
Kishida, Shuji
Yamamura, Takashi
Ohtsuka, Nobuhisa
Ling, Yan
Torii, Shinichi
Lucas, Nisha
Kuesters, Geoffrey
Steiner, Deb
Tibung, J. T.
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial
https://doi.org/10.1007/s40120-016-0059-z
Funding for this research was provided by:
Biogen
Article History
Received: 27 September 2016
First Online: 5 December 2016